Crossmark

Evaluating the efficacy of photobiomodulation therapy in the management of chemotherapy-induced peripheral neuropathy: a pilot trial (NEUROLIGHT trial)

Crossref DOI link: https://doi.org/10.1007/s10103-026-04852-1

Published Online: 2026-03-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Claes, Marithé

Lodewijckx, Joy

Robijns, Jolien

Hermans, Sylvia

Peeters, Pascal

Mebis, Jeroen
Funding

Funding for this research was provided by:

Limburg Clinical Research Center

Limburgs Kankerfonds

Kom op tegen Kanker
License Information

Text and Data Mining valid from 2026-03-14

Version of Record valid from 2026-03-14
More Information

Article History

Received: 4 June 2025

Accepted: 4 March 2026

First Online: 14 March 2026

Declarations

:

: Was obtained from all individual participants included in the study.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below